Observational Study of Blood Clotting in Bleeding and Clotting Disorders
This observational study aims to understand how blood clots form and dissolve in people with inherited or acquired bleeding and clotting disorders. Researchers will use special lab tests, including the ROTEG analyzer and thrombin generation assay, to look at your blood samples. The goal is to better understand primary and secondary hemostasis (how your body stops bleeding). You may be able to join if you are between 1 day and 98 years old and have a bleeding or clotting disorder. The study is looking to enroll up to 1000 participants. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to include up to 1000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 24 hours, suggesting a short follow-up period for this specific measurement.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Miguel Escobar, M.D. · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Assess primary and secondary hemostasis in individuals with bleeding and clotting disorders24 hours
Coagulation will be assessed by continuously recording clot firmness, thrombin generation, and platelet function